GSOL Global Sources Ltd.

-1-

-2-

-3-

This Amendment No. 1 (“ Amendment No.  1 ”) to Schedule 13D relates to the Schedule 13D filed on October 3, 2016 (as amended by Amendment No. 1, hereinafter, the “ Schedule 13D ”) by (i) York Lion, L.P., a Cayman Islands limited partnership (“ York Lion ”), (ii) York GP, Ltd., a Cayman Islands limited company (“ York  GP ”), and (iii) S. Nicholas Walker, a citizen of the United Kingdom (together with York Lion and York GP, the “ Reporting Persons ”) relating to the common stock, $0.01 par value per share, of Global Sources Ltd. (the “ Issuer ”), a Bermuda corporation with principal offices located at Canon’s Court, 22 Victoria Street, Hamilton, HM 12 Bermuda.

Capitalized terms used but not defined in this Amendment No. 1 shall have the meaning set forth in the Schedule 13D.

This Amendment No. 1 amends the Schedule 13D filed on October 3, 2016 with the United States Securities and Exchange Commission (the “ SEC ”), as follows:

Since the filing of the Schedule 13D by the Reporting Persons on October 3, 2016 reporting on the acquisition of 2,150,149 shares of the common stock of the Issuer, the Reporting Persons have acquired an additional 284,500 shares of common stock of the Issuer (the “ Additional Shares ”). The gross investment cost (including commissions) to acquire the Additional Shares was $2,537,695. The source of these funds was the working capital of York Lion.

(a) The aggregate percentage of common stock of the Issuer reported owned by each Reporting Person is based on 24,222,272 shares of common stock of the Issuer outstanding as of February 28, 2017, as reported by the Issuer in its Annual Report on Form 20-F for the fiscal year ended December 31, 2016.

York Lion beneficially owns 2,434,649 shares of common stock of the Issuer, constituting 10.05% of the outstanding shares of common stock of the Issuer. York GP may be deemed to beneficially own 2,434,649 shares of common stock of the Issuer, constituting 10.05% of the outstanding shares of common stock of the Issuer, by reason of its position as general partner of York Lion. Except to the extent of its position as general partner of York Lion, York GP disclaims beneficial ownership of such shares. Mr. Walker may be deemed to beneficially own 2,434,649 shares of common stock of the Issuer, constituting 10.05% of the outstanding shares of common stock of the Issuer, by reason of his position as the Managing Director of York GP (the general partner of York Lion). Mr. Walker owns a 9.90% interest in York Lion and Mr. Walker’s IRA owns a 0.88% interest in York Lion. Mr. Walker is also a beneficiary of a trust which owns a 21.34% interest in York Lion. Except to the extent of his position as Managing Director of York GP (the general partner of York Lion) and his interest in York Lion and said IRA and said trust, Mr. Walker disclaims beneficial ownership of the shares of the Issuer beneficially owned by York Lion.

(b) York Lion has sole voting and dispositive power with respect to the 2,434,649 shares of common stock of the Issuer beneficially owned by York Lion. By reason of its position as the general partner of York Lion, York GP may be deemed to have sole voting and dispositive power with respect to the 2,434,649 shares of common stock of the Issuer beneficially owned by York Lion. Mr. Walker may be deemed to have sole voting and dispositive power with respect to the 2,434,649 shares of common stock of the Issuer beneficially owned by York Lion by reason of his position as Managing Director of York GP.

(c) Schedule B annexed hereto lists all transactions in the Issuer’s shares of common stock during the last sixty (60) days or since the most recent filing on Schedule 13D, whichever is less, by the Reporting Persons, each of which was effected in the open market. To the knowledge of the Reporting Persons, no person listed on Schedule A to the Schedule 13D has effected a transaction in the Issuer’s shares of common stock in the last sixty (60) days.

(d) No person (including persons listed on Schedule A to the Schedule 13D) other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, such shares of common stock of the Issuer, except to the extent of such person’s position as director of an entity listed on Schedule A to this Schedule 13D.

-4-

(e) Not applicable.

[Signature page follows.]

-5-

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, we certify that the information set forth in this Amendment No 1 to Schedule 13D is true, complete and correct.

Dated: May 8, 2017

-6-

Schedule B

TRANSACTIONS BY REPORTING PERSONS

IN SHARES OF COMMON STOCK OF THE ISSUER WITHIN THE PAST 60 DAYS

The following is a list of transactions in the Issuer’s common stock by York Lion during the past sixty (60) days, all of which were stock purchases effected on the NASDAQ Global Securities Market. Other than York Lion, none of the Reporting Persons effected any transactions in the Issuer’s common stock during such period. The price per share excludes commissions.

EXHIBIT INDEX